Pfizer, Moderna to Expand Vaccine Studies in Young Children
Companies made the move after FDA told them that the initial size and scope of their studies were not enough to detect the rare side effects
COVID19 Vaccine
Pfizer-BioNTech COVID-19 Vaccine Safe, Effective in Cancer Patients
Pronounced lag in antibody production after the first dose found versus noncancer controls
CDC Advisers to Discuss Third COVID-19 Vaccine Dose for Immunocompromised
Booster shots have become a hot topic since Pfizer-BioNTech said last week it would seek EUA for a third shot of its 2-dose vaccine
Q&A: Monoclonal Antibodies for COVID-19
The IDSA recommends that antibody therapy should be administered to patients with mild to moderate COVID-19 at high risk for progression to severe disease.
ACIP: Benefits of mRNA COVID-19 Vaccines Outweigh Risks for ≥12s
After reviewing evidence, including data on risks for myocarditis, vaccination benefits outweigh risks for all populations
Many Young Cancer Survivors Report COVID-19 Vaccine Hesitancy
37.1% of adolescent and young adult cancer survivors report vaccine hesitancy; higher odds of hesitancy for females
ASCO and Friends: Cancer Patients Should Be Included in COVID-19 Vaccine Trials
A statement recommends including cancer patients and survivors in COVID-19 vaccine trials.
Myocarditis-Like Illness Reported After COVID-19 Vaccination
Case series describes 7 cases in males younger than 40 years; all patients’ symptoms were resolved by the time of hospital discharge
COVID-19 Vaccines Do Not Interfere With Male Fertility
No significant decreases seen in any sperm parameters following 2 doses of an mRNA COVID-19 vaccine
Second COVID-19 Vaccine Dose Missed by More Than 10 Percent of Americans
Adults younger than 30 most likely to have missed second dose, with nearly 12 percent outside of the 42-day allowable window
- Loading...
Loading...
Next post in News
Loading... 
Loading...